Alternatives to BiotaX

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Microbiome technology platform for developing novel therapeutics.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Personalized diagnostics for cancer genomic markers at the point of treatment.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance.

Harnessing genetic data for digital insights in rare and germline disorders.

AI platform for accelerating novel peptide therapeutic discovery and development.

Therapeutics company developing novel treatments for complex diseases.

Developing novel diagnostics to predict patient response to immunotherapy.

Israeli biotech research institute and technology accelerator focused on molecular biology.

Leveraging the adaptive immune system to diagnose and treat disease.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

PREDICTIX is an AI-powered decision support software for mental health professionals, aiding in the personalized treatment of mental health disorders.

AI-powered platform for designing novel molecular structures for new medicines.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Life science company pioneering drug discovery with AI and advanced technologies.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Compressing biology to develop the next generation of therapies.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.

Global venture capital firm backing ambitious entrepreneurs from seed to IPO across technology and life sciences.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Optimata provides software technologies for improved personalized therapy of oncology patients, predicting disease progression to optimize treatment.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Comprehensive whole-genome monitoring for cancer recurrence and progression.